Back to search

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Data up to Jan 2025

Published2003
Citations352
References52
Clinical Trials (1)

Total Citations Per Year

Abstract

References (52)

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt

1997 • 1,051 citations

Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)

2001 • 868 citations

Structure and function of the type 1 insulin-like growth factor receptor

2000 • 602 citations

A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies

1999 • 527 citations

Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.

2002 • 374 citations

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.

2002 • 371 citations

Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.

1997 • 343 citations

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

1989 • 334 citations

Insulin-like growth factor receptor expression and function in human breast cancer.

1990 • 321 citations

Insulin-like growth factor physiology and cancer risk

2000 • 299 citations

Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.

1999 • 254 citations

Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3).

1993 • 247 citations

The contradictions of the insulin-like growth factor 1 receptor

2000 • 236 citations

Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.

1989 • 233 citations

In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).

2001 • 230 citations

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.

1994 • 195 citations

Insulin‐like growth factor (IGF)‐I rescues breast cancer cells from chemotherapy‐induced cell death – proliferative and anti‐apoptotic effects

1999 • 192 citations

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

2003 • 189 citations

In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.

1994 • 186 citations

Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1.

1992 • 183 citations

A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.

1996 • 181 citations

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice.

1998 • 181 citations

Insulin-like Growth Factor Expression in Human Cancer Cell Lines

1996 • 179 citations

Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

2002 • 177 citations

Insulin-like growth factor I is a dual effector of multiple myeloma cell growth

2000 • 171 citations

Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity

2003 • 160 citations

Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors

2001 • 157 citations

Human antibodies by design

1998 • 157 citations

Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.

2001 • 141 citations

Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy

2001 • 137 citations

Epidermal Growth Factor Receptor as a Therapeutic Target in Colorectal Cancer

2003 • 121 citations

Type 1 IGF receptor in human breast diseases

1992 • 120 citations

Growth Factor Receptors in Breast Cancer: Potential for Therapeutic Intervention

2003 • 116 citations

Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer.

1991 • 115 citations

Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells

2002 • 111 citations

Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.

1986 • 104 citations

The IGF system : molecular biology, physiology, and clinical applications

1999 • 99 citations

Insulin-like growth factors and breast cancer

1995 • 96 citations

Insulin-like Growth Factor-I (IGF-I) Receptor Activation Rescues UV-damaged Cells through a p38 Signaling Pathway

2001 • 92 citations

Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells.

2002 • 92 citations

TCR-Like Human Antibodies Expressed on Human CTLs Mediate Antibody Affinity-Dependent Cytolytic Activity

2002 • 75 citations

Insulin-like Growth Factor I Receptor Antagonism Augments Response to Chemoradiation Therapy in Colon Cancer Cells

2000 • 69 citations

Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability

1996 • 49 citations

JB3, an IGF-I Receptor Antagonist, Inhibits Early Renal Growth in Diabetic and Uninephrectomized Rats

2000 • 48 citations

High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.

1992 • 45 citations

The insulin-like growth factor system as a therapeutic target in colorectal cancer

2002 • 42 citations

Characterization of Ligand Binding of a Soluble Human Insulin-like Growth Factor I Receptor Variant Suggests a Ligand-induced Conformational Change

1997 • 40 citations

Effects of insulin-like growth factor receptor inhibition on human melanomas in culture and in athymic mice.

1993 • 39 citations

Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulin-like growth factor I receptor in ovarian cancer cells

1998 • 34 citations

IGF-I Receptor Function

1999 • 31 citations

Relaxation of Insulin-Like Growth Factor-ll Gene Imprinting in Human Gynecologic Tumors

1997 • 20 citations

Monoclonal antibody therapy

2001 • 16 citations

Cited By (0)

No citing papers found in database

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks… (2003) – PubMed | Metascience Observatory Explorer